Heron Therapeutics, Inc. (HRTX) revenue

Revenue · fiscal 2025
$154.90M

Heron Therapeutics, Inc. (HRTX) reported revenue of $154.90M in fiscal 2025 (the year ended December 31, 2025). That is 7.4% higher than the $144.29M of fiscal 2024. Figures as of 18 Nov 2026, 12:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$154.90M
Change on fiscal 2024
+7.4%
Growth, 5 years
+11.8% a year
Highest on record
$154.90Mfiscal 2025
Lowest on record
$1.28Mfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Heron Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 11.8% a year. Across the 10 fiscal years on record (2016–2025), the highest was $154.90M in fiscal 2025 and the lowest $1.28M in fiscal 2016.

History · 10 fiscal years

Revenue by fiscal year

Heron Therapeutics, Inc. revenue, year by year

Heron Therapeutics, Inc. (HRTX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$154.90M 7.4% up
2024$144.29M 13.6% up
2023$127.04M 18.0% up
2022$107.67M 24.7% up
2021$86.35M 2.6% down
2020$88.64M 39.3% down
2019$145.97M 88.4% up
2018$77.47M 151.8% up
2017$30.77M 2,305.6% up
2016$1.28M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on HRTX

Heron Therapeutics, Inc., figure by figure

Heron Therapeutics, Inc. (HRTX) overview: price, valuation and scorecard

Heron Therapeutics, Inc. revenue: questions and answers

What is Heron Therapeutics, Inc.'s revenue?

Heron Therapeutics, Inc. (HRTX) reported revenue of $154.90M in fiscal 2025 (the year ended December 31, 2025). That is 7.4% higher than the $144.29M of fiscal 2024.

What is the growth rate of Heron Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 11.8% a year.

What are the highest and lowest revenue figures on record for Heron Therapeutics, Inc.?

Across the 10 fiscal years on record (2016–2025), the highest was $154.90M in fiscal 2025 and the lowest $1.28M in fiscal 2016.

How is Heron Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Heron Therapeutics, Inc. it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Heron Therapeutics, Inc. (HRTX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/HRTX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.